Search
EMA Guideline on the Development, Manufacture of Synthetic Peptides and Good Pharmacogenomic Practice
Modern medicines development increasingly sits at the intersection of advanced chemistry and genomic science. On one hand, synthetic peptides represent a fast-growing therapeutic class that bridges small molecules and biologics. On the other, pharmacogenomics is reshaping how medicines are developed, evaluated, and ultimately used in patients. Recognising these parallel advances, the European Medicines Agency (EMA) has recently published two key scientific documents: the Guid
Sharan Murugan
3 days ago3 min read